SCHEMBL1665112

SCHEMBL1665112

CC(C)C1=CC(=O)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3937352 0.85 MAPT (0.40)
SCHEMBL14632112 0.77 TLR4 (0.33)
SCHEMBL17653496 0.69
SCHEMBL17108508 0.69 MT-CO2 (0.39)
SCHEMBL13933099 0.69
SCHEMBL7054910 0.69 ALDH1A1 (0.38)
SCHEMBL19439807 0.67 PTPN1 (0.58)
SCHEMBL14381645 0.67 CRBN (0.36)
SCHEMBL18465887 0.66 BRD4 (0.32)
SCHEMBL12697758 0.66 CES2 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011048114-A1 METHOD FOR THE DIFFERENTIATION BETWEEN CROHN'S DISEASE AND ULCERATIVE COLITIS BY DETECTING VOLATILE ORGANIC COMPOUNDS IN EXHALED AIR UNIVERSITEIT MAASTRICHT (NL) 2011-04-28 WO claimed
EP-2315029-A1 Method for the differentiation between Crohn's disease and ulcerative colitis by detecting volatile organic compounds in exhaled air. Universiteit Maastricht (NL) 2011-04-27 EP claimed
US-4029106-A TOBACCO, 3-ISOPROPYL-CYCLOPENT-2-EN-1-ONE FIRMENICH S.A. (CH) 1977-06-14 US claimed
US-3937228-A Aromatic compositions FIRMENICH SA (CH) 1976-02-10 US claimed
JP-54103853-A None JP disclosed
JP-54103810-A None JP disclosed
US-20230365553-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY NOVARTIS PHARMA AG (CH) 2023-11-16 US disclosed
US-20230365553-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY NOVARTIS PHARMA AG (CH) 2023-11-16 US disclosed
EP-3088955-B1 RESIST COMPOSITION AND PATTERNING PROCESS SHINETSU CHEMICAL CO (JP) 2020-06-03 EP disclosed
US-9505765-B2 4-alkoxy/aralkoxy-5-substituted-pyrrolopyrimidine compounds as TAK1 inhibitors in disease treatment CONFLUENCE LIFE SCIENCES INC. (US) 2016-11-29 US disclosed
US-20160296509-A1 NOVEL QUINOLINE DERIVATIVES AND THEIR USE IN NEURODEGENERATIVE DISEASES MERCK PATENT GMBH (DE) 2016-10-13 US disclosed
US-20160296509-A1 NOVEL QUINOLINE DERIVATIVES AND THEIR USE IN NEURODEGENERATIVE DISEASES MERCK PATENT GMBH (DE) 2016-10-13 US disclosed
US-4029106-A TOBACCO, 3-ISOPROPYL-CYCLOPENT-2-EN-1-ONE FIRMENICH S.A. (CH) 1977-06-14 US disclosed
US-4014350-A CARYOPHYLLENE EPOXIDE AND ITS ALCOHOLS; FLAVORINGS FOR TOBACCO, FOODSTUFFS AND DRUGS FIRMENICH S.A. (CH) 1977-03-29 US disclosed
US-4009196-A HYPOTENSIVE AGENTS, BRONCHODILATORS, PROSTAGLANDIN ANALOGS TEIJIN LIMITED (JA) 1977-02-22 US disclosed
US-3989857-A Flavoring phenol or phenol derivative containing food or feed with cycloaliphatic derivatives FIRMENICH S.A. (CH) 1976-11-02 US disclosed
US-3983885-A AROMATIC COMPOSITIONS FIRMENICH S.A. (CH) 1976-10-05 US disclosed
US-3981311-A Aromatic compositions FIRMENICH S.A. (CH) 1976-09-21 US disclosed
US-3957061-A Aromatic compositions FIRMENICH S.A. (CH) 1976-05-18 US disclosed
US-3937228-A Aromatic compositions FIRMENICH SA (CH) 1976-02-10 US disclosed